Literature DB >> 10405817

Extrapineal melatonin: location and role within diffuse neuroendocrine system.

I M Kvetnoy1.   

Abstract

During the last decade, much attention has centred on melatonin, one of the hormones of the diffuse neuroendocrine system. For many years it was considered to be only a hormone of the pineal gland. As soon as highly sensitive antibodies to indolealkylamines became available, melatonin was identified not only in pineal gland, but also in extrapineal tissues. These included the retina, Harderian gland, gut mucosa, cerebellum, airway epithelium, liver, kidney, adrenals, thymus, thyroid, pancreas, ovary, carotid body, placenta and endometrium. It has also been localized in non-neuroendocrine cells such as mast cells, natural killer cells, eosinophilic leukocytes, platelets and endothelial cells. This list of cells indicates that melatonin has a unique position among the hormones of the diffuse neuroendocrine system. It is found in practically all organ systems. Functionally, melatonin-producing cells are part and parcel of the diffuse neuroendocrine system as a universal system of response, control and organism protection. Taking into account the large number of such melatonin-producing cells in many organs, the wide spectrum of biological activities of melatonin and especially its main property as a universal regulator of biological rhythms, it is now possible to consider extrapineal melatonin as a key paracrine signal molecule for the local co-ordination of intercellular relationships.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10405817     DOI: 10.1023/a:1003431122334

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  29 in total

1.  Melatonin MT-1-receptor immunoreactivity in the human eye.

Authors:  P Meyer; M Pache; K U Loeffler; L Brydon; R Jockers; J Flammer; A Wirz-Justice; E Savaskan
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

Review 2.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

3.  MTNR1B G24E variant associates With BMI and fasting plasma glucose in the general population in studies of 22,142 Europeans.

Authors:  Ehm A Andersson; Birgitte Holst; Thomas Sparsø; Niels Grarup; Karina Banasik; Johan Holmkvist; Torben Jørgensen; Knut Borch-Johnsen; Kristoffer L Egerod; Torsten Lauritzen; Thorkild I A Sørensen; Amélie Bonnefond; David Meyre; Philippe Froguel; Thue W Schwartz; Oluf Pedersen; Torben Hansen
Journal:  Diabetes       Date:  2010-03-03       Impact factor: 9.461

4.  The effects of pineal gland transplantation on the production of spinal deformity and serum melatonin level following pinealectomy in the chicken.

Authors:  Mehmet Turgut; Ciğdem Yenisey; Ayşegül Uysal; Mehmet Bozkurt; Mine Ertem Yurtseven
Journal:  Eur Spine J       Date:  2003-04-01       Impact factor: 3.134

5.  Melatonin inhibits nitric oxide production by microvascular endothelial cells in vivo and in vitro.

Authors:  C L M Silva; E K Tamura; S M D Macedo; E Cecon; L Bueno-Alves; S H P Farsky; Z S Ferreira; R P Markus
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

6.  Role of melatonin on diabetes-related metabolic disorders.

Authors:  Javier Espino; José A Pariente; Ana B Rodríguez
Journal:  World J Diabetes       Date:  2011-06-15

7.  The effect of sleep restriction and psychological load on the diurnal metabolic changes in tryptamine-related compounds in human urine.

Authors:  Masayasu Minami; Hideyo Takahashi; Tsukasa Sasaki; Shun Matsumoto; Kazuhiro Sakai; Hirofumi Inagaki; Yuko Yamano; Hirotsugu Miyake
Journal:  Environ Health Prev Med       Date:  2011-06-08       Impact factor: 3.674

Review 8.  Extrapineal melatonin: sources, regulation, and potential functions.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Carmen Venegas; María E Díaz-Casado; Elena Lima-Cabello; Luis C López; Sergio Rosales-Corral; Dun-Xian Tan; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2014-02-20       Impact factor: 9.261

Review 9.  Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene.

Authors:  H Mulder; C L F Nagorny; V Lyssenko; L Groop
Journal:  Diabetologia       Date:  2009-04-18       Impact factor: 10.122

10.  Protective effects of vitamins (C and E) and melatonin co-administration on hematological and hepatic functions and oxidative stress in alloxan-induced diabetic rats.

Authors:  Mohamed Salah Allagui; Anouer Feriani; Zouhour Bouoni; Hichem Alimi; Jean Claud Murat; Abdelfattah El Feki
Journal:  J Physiol Biochem       Date:  2014-06-13       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.